Burkholderia cepacia complex in septicaemic non-cystic fibrosis cases from two tertiary care hospitals in north India

Indian Journal of Medical Research

Volumn 131, Issue 6, 2010, Pages 829-832

  Gautam, Vikas ^a   Arora, Anita ^d   Madhup, S K ^a   Das, Anindita ^a   Vandamme, P ^e   Sharma, Kusum ^a   Koushal, Vipin ^b   Bansal, Deepak ^c   Sharma, Meera ^a   Garg, R K ^a   Rana, Sudesh ^a   Marwaha, R K ^c   Ray, Pallab ^a  

^a HOD Department of Microbiology   (India)

^b Hospital Administration   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^d ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; RECA PROTEIN;

BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; HUMAN; INDIA; LETTER; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEPTICEMIA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERTIARY HEALTH CARE; ANIMAL; BURKHOLDERIA INFECTION; CYSTIC FIBROSIS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; SEPSIS;

ANIMALS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; HUMANS; INDIA; SEPSIS;

EID: 77953345149     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Letter

References (18)

1. Mahenthiralingam E, Baldwin A, Vandamme P. Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol 2002; 51: 533-8.
2. th ed. Washington, DC, USA: ASM Press; 2007. p. 749-69.
3. Hancock REW. Resistance mechanism in Pseudomonas aeruginosa and other nonfermenter Gram-negative bacteria. Clin Infect Dis 1998; 27 (Suppl 1): S93-9.
4. Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 2000; 161: 1206-12.
5. Mukhopadhyay C, Bhargava A, Ayyagari A. Two novel clinical presentations of Burkholderia cepacia infection. J Clin Microbiol 2004; 42: 3904-5.
6. Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol 2001; 39: 1073-8.
7. Govan JRW, Brown AR, Jones AM. Evolving epidemiology of the Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol 2007; 2: 153-64.
8. Vanlaere E, Lipuma JJ, Baldwin A, Henry D, De Brandt E, Mahenthiralingam E, et al. Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol 2008; 58: 1580-90.
9. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 17th informational supplement, CLSI M100-S17. vol. 27 no.1. Wayne PA: CLSI; 2007.
10. [No authors listed]. American College of Chest Physicians. Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
11. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000; 38: 3165-73.
12. Reik R, Spilker T, LiPuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005; 43: 2926-8.
13. van Laer F, Raes D, Vandamme P, Lammens C, Sion JP, Vrints C, et al. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hosp Epidemiol 1998; 19: 112-3.
14. Agodi A, Mahenthiralingam E, Barchitta M, Giannino V, Sciacca A, Stefani S. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 2001; 39: 2891-6.
15. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002; 8: 181-7.
16. Martins KM, Fongaro GF, Dutra Rodrigues AB, Tateno AF, Azzuz-Chernishev AC, de Oliveira-Garcia D, et al. Genomovar status, virulence markers and genotyping of Burkholderia cepacia complex strains isolated from Brazilian cystic fibrosis patients. J Cystic Fibrosis 2008; 7: 336-9.
17. Speert DP. Advances in Burkholderia cepacia complex. Paediatr Respir Rev 2002; 3: 230-5.
18. Agodi A, Barchitta M, Giannino V, Collura A, Pansabene T, Garlaschi ML, et al. Burkholderia cepacia complex in cystic fibrosis and non-cystic-fibrosis patients: identification of a cluster of epidemic lineages. J Hosp Infect 2002; 50: 188-95.